- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Here are Tuesday's top research calls, including upgrades for Pandora and United Continental, and a downgrade for Abbott Labs.
In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.
Horizon Pharma is a 'giant headache,' says Jim Cramer; Abbot Labs is OK long term.